Independent Medical Education
Gilead provides funding to medical education providers and organizations to support scientific and medical education that provide objective, clinically relevant, information. This site lists independent, educational activities supported by Gilead, developed by third-party organizations. Discover a variety of educational activities through various filters. You can search by therapeutic area, activity type, resource type, and/or profession.
These medical education activities are planned, developed, and delivered by independent accredited providers in accordance with accreditation standards included in the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Gilead does not exercise control over, or provide guidance to, any accredited provider. Gilead is sharing the information on this page as a service to the medical community and with permission from the accredited providers. The information on this page is intended to provide access to educational topics of interest and most activities are free to the learner (some may require a nominal registration fee per the accredited provider’s requirements). Gilead does not support independent education, or any medical activities, for the purpose of encouraging off-label use of our products.
In recognition of accreditation standards for independent medical education, this site does not link to individual programs. You may need to select the individual program of interest on the provider's website.
Select therapeutic area(s) to view educational activities
No results for your current selections could be found.
HIV
Adjusting HIV Treatment for ART-Experienced People With HIV
In this interactive activity, an expert faculty discusses educational needs in HIV, including education on reasons that PWH may need a change in their ART regimens, and addresses the necessary effective dialogue to elicit needs and preferences related to treatment, accurate estimates of treatment adherence, and barriers to retention in care.
PVI, PeerView Institute for Medical Education
Oncology
Improving Individualized Care for Locally Advanced and Metastatic Bladder Cancer
Immunotherapies, antibody-drug conjugates, targeted therapies, and combination approaches have transformed the urothelial carcinoma landscape. Test your knowledge in this Clinical Case Challenge series using real-world patient scenarios, test results, and patient-specific factors to individualize treatment plans. Then tune in to the on-demand video for expert insights on new treatments, shared decision-making, and managing adverse events.
PRIME Education
Oncology
Inside the Issue: Integrating Antibody-Drug Conjugates into the Mgmnt of HR-Positive and Triple-Negative Metastatic Breast Cancer
This program is intended for medical oncologists, breast surgeons, hematologists, hematology-oncology fellows, radiation oncologists and other healthcare professionals involved in the treatment of breast cancer.LEARNING OBJECTIVES Appreciate the incidence of TROP2 overexpression in patients with metastatic breast cancer (mBC), and determine the current utility of TROP2-directed antibody-drug conjugates (ADCs) in the treatment of this disease. Consider available research data with novel HER2-directed ADCs for patients with HER2-low and HER2-ultralow mBC, and consider the role of this approach in routine clinical care. Discern the side effects and toxicities associated with FDA-approved ADCs for patients with mBC, and identify strategies to manage and mitigate them. Recognize the rationale for targeting other relevant cell surface proteins in patients with mBC, and consider available research findings with and the potential role in treatment of novel ADCs designed to therapeutically exploit these biomarkers. Evaluate the scientific justification for ADCs in combination with immune checkpoint inhibitor therapy, and reflect on available research findings with and ongoing trials investigating these novel regimens for patients with mBC. Recall ongoing trials evaluating the potential role of novel ADCs in the treatment of mBC, and counsel appropriate candidates regarding enrollment.
Research To Practice
Liver Diseases
Primary Biliary Cholangitis: Targeting New Treatment Goals
The goal of this activity is for learners to be better able to discuss clinical data on emerging agents for the treatment of PBC.
Medscape LLC
Oncology
What Now, What Next? Appropriate Management of mUC ~ Tweetorial #1: 1L and Maintenance Therapy in mUC
This X/Twitter-based Tweetorial explores efficacy and safety data for first-line and maintenance therapies in metastatic urothelial carcinoma.
Bonum Continuing Education LLC
Oncology
Exchanging Ideas - How to Navigate Patient-Centric Clinical Decisions in Integration of TROP2-Targeted Tx in TNBC & HR+, HER2- BC
Stay up to date on the evolving clinical role of TROP2-targeting agents and enhance your team-based, patient-centric, equitable care strategies for patients with TNBC and HR+, HER2- breast cancer.
PVI, PeerView Institute for Medical Education
Oncology
Differentiating Adverse Events for Antibody-Drug Conjugates Across Solid Tumor Management
Release Date: August 28, 2024Expiration Date: August 28, 2025Activity OverviewThis online, on-demand virtual symposium brings together renowned experts in the treatment of patients with cancer. Nurses play a crucial role in cancer care and are key members of tumor boards. Targeted therapies have revolutionized cancer treatment, presenting unique challenges and benefits. These therapies, like antibody-drug conjugates (ADCs), offer personalized care and improved outcomes, with several ADCs approved for breast and urothelial cancers. Understanding ADC mechanisms of action and toxicity profiles is essential for nurses to effectively monitor and manage treatment-related adverse events. In this educational program, these experts discuss both the effectiveness and potential adverse effects of these agents.
Physicians’ Education Resource (PER)
Oncology
Harnessing the Potential of TROP2-Targeted ADC Therapy in TNBC and HR+, HER2- Breast Cancer
This educational initiative, developed in collaboration with GRASP, will explore the evolving role of TROP2-targeting ADCs in the treatment of TNBC and HR+, HER2- MBC, focusing on the FDA-approved sacituzumab govitecan and newer agents datopotamab deruxtecan and sacituzumab tirumotecan. Through case-based discussions, experts will examine the latest efficacy and safety data on these ADCs and their evolving clinical role.
PVI, PeerView Institute for Medical Education
HIV
Managing HIV in and Aging Population
Widespread use of highly effective ART has increased the life expectancy of people living with HIV to close to that of the general population. But despite highly effective viral suppression, the risks for cardiovascular diseases continue to increase in these individuals. Jose Lucar MD describes the evidence pointing to improved interventions to better maintain the health of these aging patients.
Jointly provided by the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing
Oncology
Oncology Today with Dr Neil Love: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and TNBC
One-on-one interview (audio/video) conducted by Dr. Neil Love with Sara A. Hurvitz, MD, FACP; plus video lecture
Research To Practice
HIV
Trauma-Informed HIV Care: Meeting People Where They Are
Trauma is pervasive among people with HIV and, when unaddressed, negatively impacts engagement in care and health outcomes. Tune in as experts in HIV and mental health respond to real-world patient perspectives of lived experiences, discuss how to incorporate trauma screening into holistic HIV care, and share best practices to counsel and care for patients who have experienced trauma.
PRIME Education
HIV
The HIV Journey™: Supporting a Woman’s Lifelong Path Through Pivotal Junctions
In this interactive CME activity, Dr. Sarah Rowan discusses HIV diagnosis in women, stigma, weight gain and strategies to mitigate its effects, pregnancy and ART, postpartum care and retention in HIV care, and menopause and hormone replacement therapy in women with HIV.
This activity is provided by Integritas Communications
HIV
Multidrug-Resistant HIV: Tailoring Treatment for Challenging Cases
Antiretroviral drug resistance poses persistent challenges to achieving viral suppression. As HIV treatment options rapidly evolve, HCPs must stay abreast of the latest advancements to deliver individualized approaches while fostering long-term engagement. Tune in to gain expert insights on novel antiretrovirals positioned to optimize treatment strategies for patients with multidrug-resistant HIV.
PRIME Education
Oncology
What Clinicians Want to Know About the Management of Triple-Negative Breast Cancer
Proceedings from a webinar on June 20, 2024, moderated by Dr Neil Love.
Research To Practice
HIV
Optimizing HIV Treatment and Prevention in STI, PWID, and Underserved Populations
This case-based panel discussion and live seminar series provides expert guidance in identifying and treating patients at-risk of HIV infection, including those with STIs and in underserved areas. Recent HIV prevention and treatment strategies are reviewed and discussed, providing program participants with current best practices.
Jointly provided by Partners for Advancing Clinical Education (PACE) and ViralEd, Inc.
Oncology
Maximizing the Role of ADCs in Urothelial Carcinoma: Practical Tips for Patient Selection, Safety Mgmnt and Collaborative Care
In this PeerView educational activity, based on a recent live symposium and brought to you by PeerView Live and the Bladder Cancer Advocacy Network (BCAN), a panel of experts illustrate key clinical decision points through a lively discussion of patients drawn from their own practice while providing foundational knowledge on the science and clinical evidence supporting the use of ADCs in a variety of settings.
PVI, PeerView Institute for Medical Education
HIV
Top 10 Key Concepts in Rapid ART: Primary Care and HIV Treater Editions
Over the last several years, rapid antiretroviral therapy (ART) has been recommended in guidelines and has begun to be widely implemented. However, many clinics still face barriers and clinicians are unsure about rapid ART requirements and which patients are eligible. Both primary care providers and HIV treaters can begin rapid ART, though primary care providers may need additional guidance on rapid ART recommendations. These activities answer the most common questions regarding rapid ART recommendations and implementation.
Integritas Communications
HIV
Using PrEP and HIV Treatment Guidelines in the Real World: Understanding Patient and Clinician Experience
These online clinical case modules review the current treatment guidelines on both PrEP and HIV treatment and management. Participants will be able to apply the major guidelines to the identification of individuals at risk for HIV infection, determine the appropriateness of using PrEP in individual patients and implement and manage both PrEP and current HIV treatment strategies. Additional case modules will be added in the fall of 2024.
Jointly provided by Partners for Advancing Clinical Education (PACE) and ViralEd, Inc.
Liver Diseases | HIV
Managing HIV Coinfections: HBV and TB
Current ART regimens can successfully manage HIV infection in nearly all PLWH. But what happens when a patient with HIV is coinfected with a dangerous pathogen ART alone cannot handle? Two of the most common are hepatitis B and latent tuberculosis infection.How does ART selection and dosing need to change? Which agents should be avoided? What can a clinician do to get a patient to accept TPT — TB preventive therapy — for a disease that’s currently without symptoms?Join Drs. Sonya Krishnan and Zachary Lorenz from the Johns Hopkins School of Medicine as we discuss the special needs of managing PLWH with coinfections — in this issue of eHIV Review.
Jointly provided by the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing
HIV
ART, HRT, Pregnancy, and Menopause in Women Living With HIV
Pregnancy and menopause — for many women, these are two of the most significant healthcare events in their lives. For WLWH (women living with HIV) and their healthcare providers, managing these life-changing periods is often complicated by many questions.Is HRT (hormone replacement therapy) safe? Is it appropriate for contraception as well as relief of menopausal symptoms? How might hormone replacement therapy interact with their current ART regimen? Does living with HIV induce early menopause? What does the evidence say?Join us, as we discuss these issues with Dr. Anna Powell, Assistant Professor of Gynecology and Obstetrics at the Johns Hopkins University School of Medicine, in this issue of eHIV Review.
Jointly provided by the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing
HIV
Adapting HIV Treatment for People With Substance Use Disorder
In this activity, an expert discusses how to adapt HIV treatment for people with substance use disorders, exploring barriers to management, effective communication strategies, coordinating care with mental health and substance use treatment providers, and guideline recommendations for developing HIV care plans.
PVI, PeerView Institute for Medical Education
Oncology
Improving the Pt Experience with TNBC Tx: Fostering Equity in Hispanic and Latina Pop Part 1: Updates on Mgmnt of Metastatic TNBC
Current Treatment of Metastatic TNBC; Importance of biomarker testing; Overview of first-line and second-line treatment options; Key clinical trial data supporting approved agents; Treatment Selection and Sequencing; Guideline-based approaches; How does prior therapy influence sequencing?; How do biomarkers and patient characteristics guide treatment decision-making?
PlatformQ Health, with Global Education Group, and advocacy partners Salud America and Surviving Breast Cancer
Liver Diseases
Taking Aim at Primary Biliary Cholangitis
This activity includes discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.
Medscape LLC
HIV
What’s New with HIV and PrEP: Critical Updates for Pharmacists
The HIV treatment and prevention landscape is rapidly changing. In the last few years, important new information has been released, including changes to dose intervals and treatment initiation regimens, and the use of some of these drugs in special populations. There's also new, promising data on in-development treatment and prevention options, including the latest news on semiannual injectable PrEP! Watch this free CME/CE webcast for updates.
DKBmed
Oncology
Virtual Case Library: Metastatic Triple-Negative Breast Cancer
Proceedings of a virtually recorded roundtable discussion between junior clinical investigators and faculty
Research To Practice
HIV
Issues Facing Women Living with HIV
In this issue of eHIV Review, Anna Maya Powell, MD, MS, Assistant Professor of Gynecology and Obstetrics at the Johns Hopkins Bayview Medical Center, breaks down not only the considerable burdens in WLWH, but also the unique treatment approaches for this population as well as updated considerations on perinatal HIV transmission risk through breast/chest feeding.
Jointly provided by the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing
Oncology
Optimal Sequencing of ADCs in Endocrine Refractory HR+/HER2- Metastatic Breast Cancer
The addition of antibody-drug conjugate (ADC) therapies to the treatment armamentarium for endocrine-refractory, HR-positive, HER2-negative metastatic breast cancer has greatly improved outcomes for patients in this setting. However, selecting the appropriate ADC and determining the optimal sequencing of these therapies may be challenging. In this activity, expert faculty in the field of breast cancer review the clinical burden related to endocrine-refractory disease, the role of ADCs in this setting, and best practices for the sequencing of these agents
Prova Education
HIV
Mental Health and HIV Webinar Series – Substance Use Disorders and HIV
The American Academy of HIV Medicine hosted a series of webinars, both live and endured for CME, on select topics related to mental health and HIV. The fourth and final in the series was on topics related to Substance Use Disorders and HIV. Designed for the health care professional, this webinar examines the clinical manifestation of substance use disorders and HIV, diagnostic criteria, etiology and physiology of substance use disorders; the impact on health and evidence based interventions – including the prescribing and monitoring of psychotropic medications.
American Academy of HIV Medicine
HIV
Conversations in HIV: Patient Voices Guiding Physician Choices
This case-based activity features an expert roundtable discussion with Drs. Meredith E. Clement, Amesika N. Nyaku, and David A. Wohl on management approaches for different patient types living with HIV. In this series, we incorporate patient voices highlighting their experiences and concerns during their journey with HIV. In addition, Drs. Clement, Nyaku, and Wohl provide helpful insights on how to listen for and interpret patient cues that may help clinicians individualize and improve HIV care. The activity includes PowerPoint slides detailing relevant supporting data as a downloable educational resource.
This activity is jointly provided by the University of Nebraska Medical Center and Practice Point Communications
HIV
CCO Official Conference Coverage of AIDS 2024
Produced in partnership with the International AIDS Society, this Conference Coverage program communicates key data presented at AIDS 2024 on HIV prevention studies, treatment strategies, and new and investigational ART regimens. Featuring slide-based Capsule Summaries of the major studies, on-demand webcasts, downloadable slides, and regional perspectives through ClinicalThought commentaries.
Clinical Care Options
HIV
Navigating HIV in the Aging Population: Advanced Clinical Insights
In this issue of eHIV Review, Jose A. Lucar, MD, Associate Professor at The George Washington University, explores CV risk-reduction strategies as well as issues related to polypharmacy and neurocognitive decline in older PLWH. Learners will expect to improve their ability to assess and better address factors in the aging and older HIV population that complicate treatment or warrant special considerations for management.
Jointly provided by the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing
Oncology
New Approaches to Earlier Lines of Therapy in TNBC
Many novel treatments have emerged in recent years for triple-negative breast cancer (TNBC), and several new treatments are under investigation both in the metastatic and early disease settings. Despite these advances, Hispanic and Latina women with TNBC continue to have poor outcomes due to major disparities in treatment. This is the second of 3 sessions.
Medlive (PlatformQ Health), Surviving Breast Cancer, SaludAmerica, Global Education Group (accredited provider)
HIV
HIV Prevention for Black Women: Overcoming Barriers and Enhancing Access
Despite advancements in HIV prevention, Black women are disproportionately impacted by HIV and face barriers to accessing PrEP. To address this urgent need, clinicians must be equipped with strategies to elevate awareness and ensure equitable access to HIV prevention. Join experts, Oni Blackstock, MD, MHS and Jewel Sawyer, PA-C, MSHS, as they share insights on approaches for achieving health equity and the latest PrEP recommendations.
PRIME Education
HIV
Improving Equity in PrEP for People Experiencing Homelessness Through Structural Interventions
Join HealthHIV for a 75 minute live webinar exploring challenges and strategies in PrEP outreach to people experiencing homelessness (PEH). As part of the series, "PrEP for People Experiencing Homelessness," this activity offers 1.25 credits/contact hours, delving into structural interventions, innovative PrEP models, and community partnerships to enhance equity in access. Engage with experts, participate in polls, and access resources for effective PrEP care.
HealthHIV and Medical Learning Institute, Inc. (MLI)
HIV
Breaking Barriers: An Educational Toolkit for Empowering Immigrant Communities in HIV Prevention
Due to numerous unique challenges, immigrants are often highly vulnerable to acquiring HIV. This Educational Toolkit includes resources to help you lead interactive, community-based educational sessions designed to engage immigrants in building health literacy, thereby increasing awareness of local HIV testing and prevention services, and access to resources where they can receive support.
PRIME Education
Oncology
Novel and Emerging Evidence in Early-Stage Breast Cancer
Novel and emerging therapies are enabling a more individualized approach to care in early-stage breast cancer. As immunotherapy and targeted agents move into earlier lines of treatment, ensure your team is current on evidence-based treatment strategies and updated guideline recommendations.
PRIME Education
Oncology
On Target: Integrating Trop-2-Directed Therapeutics for Urothelial Carcinoma With Precision
Are you ready to explore treatment options for improving care in urothelial cancer? Discover more by engaging with this series of micro-learning activities aimed at enhancing your understanding and expertise in modern bladder cancer management, including Trop-2‒targeting ADC protocols.
PVI, PeerView Institute for Medical Education
Oncology
Optimizing Treatment With Infusion-Based Therapies for HR+/HER2- and Triple-Negative Breast Cancer
Tune in to this recording from the HOPA Annual Conference 2024 to learn cutting-edge strategies for pharmacists to optimize use of novel infusion-based therapies for treatment of advanced and metastatic breast cancer, such as antibody-drug conjugates. Combine this knowledge with a concise point-of-care resource containing evidence-based best practices and recommendations for administering infusion therapies and managing therapy-associated AEs.
PRIME Education
HIV
Re:Mind—Making Mental Health Care an Integral Part of HIV Care
A critical component of holistic HIV care is treating patients’ mental health. This program will offer strategies for identifying patients with or at risk for mental health conditions, integrating mental health support in HIV care, and addressing barriers to HIV treatment persistence and engagement, through a foundational text module and series of case studies—each with a dedicated video module, slideset, podcast, and infographic.
Clinical Care Options
HIV
Transcending Barriers, Transforming Outcomes: Improving HIV Care for Transgender People Living With HIV
Take home expert-informed strategies to improve linkage and retention in HIV care for transgender people living with HIV, including how to address challenges to ART adherence and provide gender-affirming healthcare, through on-demand webcasts with accompanying slides, ClinicalThought commentaries, and podcast episodes.
Clinical Care Options
Liver Diseases | HIV
Addressing Management Challenges in HIV with Comorbid Infections
People living with HIV (PLWH) face an increased risk of comorbid infections such as hepatitis B virus (HBV), hepatitis C virus (HCV), and tuberculosis (TB). Consequently, clinicians may be challenged in their ability to evaluate and implement optimal treatment regimens to manage PLWH with comorbid infections.In this issue of eHIV Review, Sonya Krishnan, MD, MHS, Assistant Professor of Medicine at Johns Hopkins Medicine, and Zachary W. Lorenz, MD, Infectious Diseases Fellow at Johns Hopkins University School of Medicine, discuss ways to improve and optimize the management protocols for PLWH and comorbid infections according to current guidelines. Learners will expect to improve their awareness of the latest advancements in HCV, HBV, and TB treatments and how to incorporate these therapies appropriately in the overall management of HIV.
Jointly provided by the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing
Liver Diseases | HIV
Optimal Management of HIV Disease & Hepatitis: Clinical Conference XXXII (OPMAN) – Enduring Video Archive
We are pleased to have recently held the Optimal Management of HIV Disease & Hepatitis: Clinical Conference XXXII (OPMAN). The conference took place March 16-17, 2024, in Baltimore, Maryland with leading clinicians and researchers presenting an array of topics covering HIV disease and liver disease. The presentations offered a unique distillation of clinically focused data tailored for practicing HIV and hepatitis healthcare professionals.These accredited enduring video archives of OPMAN XXXII provide access to each day of the conference, including clinical presentations, interactive case discussions, and panel discussions addressing audience questions. Continuing education credit is provided for each segment, so you may participate in your area(s) of interest. We hope you enjoy this activity!
Rush Unviversity Medical Center
HIV
STIs in the Era of PrEP: Navigating the Latest Advances in Sexual Wellness
Rising rates of STIs highlight the importance of optimizing screening, prevention, and treatment to address the syndemic of STIs and HIV. Tune in to hear experts share insights on the latest developments in STI prevention, screening and treatment, differentiating and personalizing HIV prevention plans, engaging in shared decision-making for holistic HIV prevention.
PRIME Education
HIV
Living Well With HIV: A Patient Education Toolkit for Healthcare Providers on Optimizing ART Adherence
Adherence to ART can be challenging but is essential to living a long and healthy life with HIV. This toolkit includes resources to help you lead interactive education sessions designed to empower people living with HIV to take their ART regularly, recognize and fight HIV-related stigma, and learn strategies to improve their overall well-being.
PRIME Education
Oncology
Virtual Case Library: Metastatic Urothelial Bladder Cancer
Proceedings of a virtually recorded roundtable discussion between junior clinical investigators and faculty.
Research To Practice
Oncology
Peer Pressure: How Well Do You Know Your ADCs? Cracking the Code of Targeted Delivery of Cytotoxic Payloads in Lung Cancer
This unique educational activity, based on a recent live symposium held adjunct to the IASLC 2024 Targeted Therapies of Lung Cancer Meeting, features entertaining quiz-based Peer Pressure Challenges during which top experts are put on the spot to compete against each other and test their knowledge about ADCs.
PVI, PeerView Institute for Medical Education
Oncology
What Now, What Next? Appropriate Management of mUC ~ How I Practice #1: Treatment Landscape of mUC
This activity, a X/Twitter-based How I Practice video focuses on the treatment landscape in first-, second- and subsequent-lines of therapy in metastatic urothelial carcinoma.
Bonum Continuing Education LLC
Oncology
The Patient-Clinician Alliance to Enhance Care for Patients With Metastatic Breast Cancer on Antibody-Drug Conjugates
In this activity, an expert in oncology and a patient advocate discuss strategies to optimize care for patients with metastatic breast cancer using antibody-drug conjugates. Upon completion of this activity, learners should be able to identify the rationale for targeted ADCs in the treatment of patients with mBC, and outline patient-focused strategies to optimize the use of ADCs in appropriate patients with mBC.
Global Education Group
HIV
You’re Welcome! Ensuring HIV Services Are Inclusive and Equitable
A set of practical resources exploring how clinicians can facilitate successful patient outcomes by providing welcome services at each stage of the HIV care continuum, from initial interactions around linkage to care and ART initiation, through to long-term adherence to ART and persistent engagement with care, through to reconnecting to care after a period of interruption.
Clinical Care Options
Oncology
Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy in TNBC and HR+, HER2- Breast Cancer
This PeerView educational activity, developed in partnership with GRASP and The Chrysalis Initiative, provides multidisciplinary professionals with the latest clinical data on the role of TROP2-targeting ADCs in breast cancer and guidance on the optimal utilization of TROP2-targeting ADCs in TNBC and HR+, HER2- breast cancer in the context of current evidence and expert recommendations.
PVI, PeerView Institute for Medical Education
HIV
Mental Health and HIV Webinar Series – Anxiety and Stress and HIV
The American Academy of HIV Medicine hosted a series of webinars, both live and endured for CME, on select topics related to mental health and HIV. The second in the series was on topics related to Anxiety and Stress. Designed for the health care professional, this webinar examines the clinical manifestation of anxiety and stress and HIV, diagnostic criteria, etiology and physiology of anxiety and stress’s impact on health and evidence based interventions – including the prescribing and monitoring of psychotropic medications.
American Academy of HIV Medicine
COVID-19 | HIV
Two in One HIV and COVID Screening & Testing Model Training Series
The Two in One Model training series includes a range of topics that historicize and contextualize HIV and COVID disparities among minoritized populations. With this understanding, PCPs can address the ongoing stigma and disparities disproportionately impacting these groups while routinizing HIV and COVID screening and testing for all patients.
GW School of Medicine & Health Sciences
HIV
Mental Health and HIV Webinar Series – Neurocognitive Disorders and HIV
The American Academy of HIV Medicine hosted a series of webinars, both live and endured for CME, on select topics related to mental health and HIV. The third in the series was on topics related to Neurocognitive Disorders and HIV. Designed for the health care professional, this webinar examines the clinical manifestation of neurocognitive disorders and HIV, diagnostic criteria, etiology and physiology of neurocognitive disorders; the impact on health and evidence based interventions – including the prescribing and monitoring of psychotropic medications.
American Academy of HIV Medicine
HIV
Sex Ed 101: An Educational Toolkit for Discussing HIV Prevention and Sexual Health With Young Adults
Given the high rates of new HIV and STIs among young adults, improving preventative services for this demographic is a top public health priority. However, many in this age group are unaware of HIV/STI prevention options. This toolkit includes resources to help you lead interactive education sessions to empower young adults to take control of their sexual health.
PRIME Education
HIV
HIV Treatment in Rural and Underserved Communities: Guideline Updates, New Evidence, and Best Practices
This activity will review HIV treatment approaches, current guideline recommendations and clinical trial evidence, and interventions to optimize the care continuum in rural and underserved communities.
Talem Health, LLC
HIV
HIV Prevention and PrEP: Laying the Foundation
In this online, on-demand activity, expert faculty will cover best practices for discussing sexual history and the need for PrEP with patients in an open, nonjudgmental manner. Evidence-based guidance for initiating and maintaining appropriate candidates on PrEP will also be reviewed.
Talem Health, LLC
HIV
Protecting Black Women From HIV: An Educational Toolkit for Enhancing Sexual Wellness
Rising rates of new HIV among Black women highlight the need for improving awareness and access to preventative services. This toolkit provides resources for you to lead interactive educational sessions aimed at empowering Black women to confidently advocate for their sexual health. The toolkit covers HIV prevention strategies, conversation tips to discuss sexual health, and guidance to identify local resources.
PRIME Education
HIV
HealthHIV’s HIV Prevention Certified Provider™ Certification Program
The HealthHIV HIV Prevention Certified Provider™ Program is a self-paced, online CME-accredited program composed of seven 60-minute modules for clinicians to employ effective HIV prevention interventions. This activity provides insight and knowledge on HIV epidemiology, risk identification, prevention strategies, PrEP implementation, and cultural humility. Upon completion, participants are awarded designation as an HIV Prevention Certified Provider™ (“HIVPCP”) and are included in the national directory alongside hundreds of other HIVPCPs.
HealthHIV and Medical Learning Institute, Inc. (MLI)
HIV
Shattering Stigma: Redefining HIV Care Through Dialogue
In this activity designed for clinical and nonclinical members of the HIV care team, expert faculty will review best practices to maintain open communication with patients, avoid making assumptions, and address barriers to care
Talem Health, LLC
HIV
HIV Care and Support: Best Practices for Creating a Welcoming and Inclusive Clinic Environment
In this activity designed for clinical and nonclinical members of the HIV care team, expert faculty will demonstrate how to create a welcoming, stigma-free clinic environment starting at the front desk.
Talem Health, LLC
HIV
Special Considerations for PrEP Care Among People Experiencing Homelessness
During the 60-minute webinar, two experts will discuss the unique challenges, opportunities, and strategies for outreach and engagement of people experiencing homelessness (PEH) in PrEP services. The experts will share model practices, highlight patient case examples, and discuss strategies for engaging PEH in PrEP, such as PrEP medication adherence and persistence, adherence to medical appointments, and addressing common comorbidities.
Provider: HealthHIV and Medical Learning Institute, Inc. (MLI)
HIV
A Holistic Approach: Shared Decision-Making in Diverse People Living With HIV
Collaboration between patients and providers is crucial to optimize HIV care, particularly for people with diverse needs, who often face increased barriers and stigma. In this video, HIV experts discuss common barriers to engagement within diverse communities, strategies to empower diverse individuals in getting the HIV care they need, and real-world outcomes from a recent quality improvement initiative.
PRIME Education
Oncology
Matching the Right Patients to the Right Therapies in TNBC: Case-Based Applications
2023 SABCS Satellite Symposium and enduring program
Physicians' Education Resource, LLC (PER)
Oncology
Advancing Personalized Care in HR+/HER2- and Triple-Negative Breast Cancer
The rapidly evolving treatment landscape for HR+/HER2- and triple-negative breast cancer is enabling individualized treatment decision-making and improving patient outcomes. Stay up to date with the latest developments and tune in to hear expert discussion on the latest clinical evidence in HR+/HER2- and TNBC management, evidence-based strategies for treatment sequencing, and monitoring & mitigating treatment-related adverse events.
PRIME Education
Oncology
Clinical Updates -Utilizing Social Media & Traditional Online Learning to Provide Rapid Updates from Important Society Meetings
Clinically impactful updates from the SABCS Annual Meeting featuring the Oncology Brothers and Drs. Tolaney, Graff, Hamilton and Lustberg
Integrity Continuing Education
HIV
Keeping Pace With the Science: Practical Implementation of Long-Acting ART
HIV treatment is quickly evolving, with novel long-acting ART representing a significant change in treatment paradigms. These advances challenge HCPs to stay up to date on the latest evidence and guidelines while navigating barriers to implementation. Tune in as experts discuss clinical evidence comparisons between existing/emerging ART, practical tips for introducing long-acting ART, and implications for ART accessibility and adherence
PRIME Education
HIV
Improving HIV Care and Outcomes in Rural and Underserved Populations: A Case-Based Approach to Meeting the Needs and Challenges
This case-based activity will cover best practices for initiating antiretroviral therapy quickly, considerations for switching or simplifying HIV therapy, and how to manage special patient populations.
Talem Health, LLC
HIV
Putting PrEP Into Practice: A Case-Based Collaborative Approach
In this online, on-demand activity, expert faculty will discuss available PrEP formulations and considerations for its use in different populations. Best practices for initiating and maintaining patients on PrEP will also be reviewed through a series of interspersed, case-based discussions.
Talem Health, LLC
Liver Diseases
Are We Early Enough? Key Questions in Timely Management of HBV and HDV
Hear expert insights from healthcare professionals on the benefits of eary identification of HBV and HDV, early HBV treatment, and the role of primary care providers in enhancing early engagement in HBV care through a series of virtual symposia. Reinforce your learning with an on-demand video, podcasts, downloadable slides, and expert commentaries.
Clinical Care Options
HIV
PrEP’ing in the 2020s: Empowering PCPs to Prevent HIV
This activity is designed to empower and educate participants to offer preexposure prophylaxis (PrEP) for HIV prevention in the primary care setting. Participants will learn how to identify patients at high risk for acquiring HIV, and how to have non-biased conversations about sexual health. Through a patient-centered lens, the activity will cover implementation of PrEP services, including how to select an oral or long-acting injectable regimen based on clinical evidence and patient characteristics and preferences, and how to initiate, monitor, and provide follow-up.
Integritas
HIV
U=U to Combat HIV Stigma
In this activity designed for clinical and nonclinical members of the HIV care team, expert faculty will cover ways to dispel misconceptions about HIV and treat patients in a respectful and nonjudgmental manner that maintains their privacy.
Talem Health, LLC
Oncology
Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Patients with ER-Positive MBC — An ISS **
Proceedings from a live event on December 5, 2023, held in partnership with the 2023 San Antonio Breast Cancer Symposium® and moderated by Dr Neil Love. (**An Independent Satellite Symposium (ISS) Held in Conjunction with the 46th Annual San Antonio Breast Cancer Symposium)
Research To Practice
Oncology
Conversations in Advanced NSCLC: Rationale and Utility of TROP2 Antibody-Drug Conjugates Based on Updates from WCLC and ESMO
In this roundtable discussion, leading experts will inform and guide on the safety and efficacy of TROP2-directed ADCs reported at key conferences such as WCLC and ESMO.
Practice Point Communications LLC, Benjamin Levy, MD; Aaron Lisberg, MD; Alexander Spira, MD, PhD, FACP
Oncology
CCO Independent Conference Highlights of the European Society for Medical Oncology 2023 Congress
Review a conference preview commentary on experts’ abstracts to watch, Capsule Summary slidesets, and an expert analysis of key studies from ESMO 2023
Clinical Care Options
HIV
Getting Personal: Reassessing HIV Management to Better Individualize Treatment Across the Ages
In this activity, an expert discusses identifying barriers that threaten ending the HIV epidemic, current and emerging treatment options in HIV management, and ways to personalize treatment for patients living with HIV to improve outcomes and adherence.
PVI, PeerView Institute for Medical Education
HIV
Fighting Frailty in PLWH: Expert Guidance on Individualizing Care for Frail PLWH
Frailty affects the clinical status of older people living with HIV (PLWH), increasing their risk of adverse outcomes while impacting quality of life and health span. The goal of this activity is for learners to be better able to improve awareness of the burden and contributing factors that are associated with frailty for PLWH, and increasing adoption of best practice in screening, management, and guideline-based care for PLWH who are frail.
Provider: Medscape, LLC
HIV
Life Happens: Thriving With HIV Through Major Life Transitions
Learn from experts how to ensure retention in HIV care and respond to evolving medical and other needs in persons living with HIV experiencing
Provider: Clinical Care Options
HIV
HealthHIV’s HIV PrEP Navigation Certification Program
The HealthHIV HIV PrEP Navigation Certification (HIVPNC) equips providers with the skills to guide individuals in ongoing PrEP use. This program empowers both clinical and non-clinical professionals with inclusive and affirming PrEP navigation services, grounded in current data and best practices. Certification demonstrates a commitment to assisting patients in choosing, accessing, and adhering to PrEP, as well as navigating life changes affecting their PrEP care. Successful completion results in the HIVPNC and inclusion in the national directory.
HealthHIV and Medical Learning Institute, Inc. (MLI)
HIV
Keeping It Simple: Strategies Across the HIV Care Continuum
Watch video discussions, listen to a podcast, download slidesets, and read commentary insights as global HIV experts and individuals living with HIV explore how simplicity in HIV management strategies across the care cascade addresses the desires of people living with HIV to minimize the impact of HIV in their lives and the needs of healthcare professionals to minimize complexity in patient care.
Clinical Care Options
HIV
PrEP Roadmap: Where Are We and Where Are We Going?
Learn about the revolutionary impact of current PrEP regimens, the barriers preventing today’s PrEP regimens from reaching their full potential, and how the next generation of PrEP modalities may address unmet needs and take us closer to a future without HIV with podcasts, a module, ClinicalThought commentaries, and downloadable slides.
Clinical Care Options
Liver Diseases
Hep B Consult: US, European, and Asian-Pacific Guideline Recommendations on Whether and How to Treat HBV and HDV
Learn guideline-based patient-specific HBV and HDV management recommendations using this Interactive Decision Support Tool.
Clinical Care Options